ABSTRACT NUMBER: ESOC2026A1415 INTRAVENOUS THROMBOLYSIS PLUS ENDOVASCULAR TREATMENT VERSUS ENDOVASCULAR TREATMENT ALONE IN ACUTE ISCHAEMIC STROKE PATIENTS PRESENTING AT PRIMARY STROKE CENTERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Abstract Background and aims Intravenous thrombolysis (IVT) is routinely administered, when not contra-indicated, in patients with acute ischaemic stroke (AIS) and large-vessel occlusion (LVO) who present at primary stroke centers [PSCs; centers without capability for endovascular treatment (EVT)] and are subsequently transferred for EVT. However, it is unknown whether IVT plus EVT (bridging therapy) is beneficial compared to EVT-alone in this setting. This study aims to evaluate the efficacy and safety of bridging therapy compared to EVT-alone in patients with LVO-AIS presenting at PSCs. Methods We performed a systematic literature search of MEDLINE, SCOPUS, and conference proceedings through January 3, 2026. Eligible studies included randomised or observational cohort studies enrolling patients with LVO-AIS presenting at PSCs, comparing bridging therapy with EVT-alone. Meta-analysis was performed using the random-effects model and calculating pooled odds ratios (ORs). Results Thirteen observational studies were included, comprising a total of 2,665 patients treated with bridging therapy versus 3,156 patients treated with EVT alone. Bridging therapy was associated with increased odds of good functional outcome (mRS 0-2; OR: 1.60; 95%CI: 1.31-1.95; p<0.01), excellent functional outcome (mRS 0-1; OR: 1.83; 95%CI: 1.49-2.24; p<0.01), and reduced disability at 90 days (≥1-point mRS improvement; common OR: 1.70; 95%CI: 1.23-2.36; p<0.01). Symptomatic intracranial haemorrhage was similar between the two groups (OR: 0.92; 95%CI: 0.71-1.19; p=0.52), while 90-day mortality was significantly lower in the bridging therapy (OR: 0.65; 95%CI: 0.52-0.82; p<0.01). Conclusions Pooled evidence from observational studies supports bridging therapy over BMT alone in patients with LVO-AIS presenting at PSCs. Conflict of interest Nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.681
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1415 INTRAVENOUS THROMBOLYSIS PLUS ENDOVASCULAR TREATMENT VERSUS ENDOVASCULAR TREATMENT ALONE IN ACUTE ISCHAEMIC STROKE PATIENTS PRESENTING AT PRIMARY STROKE CENTERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Odysseas Kargiotis, Lina Palaiodimou, Apostolοs Safouris, Νικόλαος Παπαγεωργίου et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A1415 INTRAVENOUS THROMBOLYSIS PLUS ENDOVASCULAR TREATMENT VERSUS ENDOVASCULAR TREATMENT ALONE IN ACUTE ISCHAEMIC STROKE PATIENTS PRESENTING AT PRIMARY STROKE CENTERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Odysseas Kargiotis, Lina Palaiodimou, Apostolοs Safouris, Νικόλαος Παπαγεωργίου, Georgios Magoufis, Stavros Spiliopoulos, Georgios Tsivgoulis, Maria Chondrogianni, Aikaterini Theodorou, Eleni Bakola
article en

Abstract

Abstract Background and aims Intravenous thrombolysis (IVT) is routinely administered, when not contra-indicated, in patients with acute ischaemic stroke (AIS) and large-vessel occlusion (LVO) who present at primary stroke centers [PSCs; centers without capability for endovascular treatment (EVT)] and are subsequently transferred for EVT. However, it is unknown whether IVT plus EVT (bridging therapy) is beneficial compared to EVT-alone in this setting. This study aims to evaluate the efficacy and safety of bridging therapy compared to EVT-alone in patients with LVO-AIS presenting at PSCs. Methods We performed a systematic literature search of MEDLINE, SCOPUS, and conference proceedings through January 3, 2026. Eligible studies included randomised or observational cohort studies enrolling patients with LVO-AIS presenting at PSCs, comparing bridging therapy with EVT-alone. Meta-analysis was performed using the random-effects model and calculating pooled odds ratios (ORs). Results Thirteen observational studies were included, comprising a total of 2,665 patients treated with bridging therapy versus 3,156 patients treated with EVT alone. Bridging therapy was associated with increased odds of good functional outcome (mRS 0-2; OR: 1.60; 95%CI: 1.31-1.95; p<0.01), excellent functional outcome (mRS 0-1; OR: 1.83; 95%CI: 1.49-2.24; p<0.01), and reduced disability at 90 days (≥1-point mRS improvement; common OR: 1.70; 95%CI: 1.23-2.36; p<0.01). Symptomatic intracranial haemorrhage was similar between the two groups (OR: 0.92; 95%CI: 0.71-1.19; p=0.52), while 90-day mortality was significantly lower in the bridging therapy (OR: 0.65; 95%CI: 0.52-0.82; p<0.01). Conclusions Pooled evidence from observational studies supports bridging therapy over BMT alone in patients with LVO-AIS presenting at PSCs. Conflict of interest Nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
National and Kapodistrian University of Athens (GR), General University Hospital of Patras (GR), University General Hospital Attikon (GR), Metropolitan Hospital (GR)
Good health and well-being
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.